Advocacy intelligence hub — real-time data for patient organizations
Sixth Affiliated Hospital, Sun Yat-sen University — PHASE2
University Health Network, Toronto — PHASE2
National Cancer Institute, Naples
Latin American Cooperative Oncology Group
Centre Hospitalier Universitaire de Besancon — PHASE2
Centre Hospitalier Universitaire de Besancon — PHASE2
Umeå University — NA
Brigham and Women's Hospital — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs2
Bavencio
(avelumab (Recombinant human monoclonal IgG1 antibody against programmed death ligand-1))Orphan drugstandardEMD Serono Research and Development Institute, Inc.
Programmed Death Ligand-1 Blocker [EPC]
12.1 Mechanism of Action PD-L1 may be expressed on tumor cells and tumor-infiltrating immune cells and can contribute to the inhibition of the anti-tu...
Christian S Hinrichs, MD, M.D
Rutgers Cancer Institute
📍 BETHESDA, MD
Cathy Eng
Yale University Cancer Center LAO
John Welch, MD, PhD
A2 Biotherapeutics
Vincent Chung, MD
City of Hope Medical Center
📍 DUARTE, CA
Stephen J Russell, MD, Ph.D.
Clinical Lead
Diwakar J Davar, MD
UPMC Hillman Cancer Center
📍 PITTSBURGH, PA
View all Squamous cell carcinoma of the rectum specialists →